| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.25 | 4e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |